You now have one more reason to hate 32-year-old Martin "Cerebral" Shkreli.
Shkreli, the chairman of the League of Legends Team Imagine and the pharmaceutical company owner who bought the rights to a drug used by people with compromised immune systems, including those with AIDs, and then bumped its price from $13.50 a tablet to $750 a pop, also happens to be the until-today secret winning bidder of the only copy of Wu-Tang Clan's latest album.
Once Upon a Time in Shaolin was pitched as a piece of Wu-Tang Clan produced art, an album — which is apparently breathtaking and features some vocals from Cher — that will only ever exist as a single record owned by one person.
That person, thanks to a rumored $2 million bid, according to Bloomberg News, is Shkreli.
The 32-year-old serial entrepreneur tells the pub that he wants to pay more musicians to make exclusive music for him and that he hasn't yet listened to the fabled album that he paid so much for. He's waiting, he said, for a time when he needs his spirits lifted .... or maybe a request from Taylor Swift for a private listening session.
"I could be convinced to listen to it earlier if Taylor Swift wants to hear it or something like that," Shkreli told Bloomberg. "But for now, I think I'm going to kind of save it for a rainy day."
For the band's part, they said the deal was closed before Shkreli made a name for himself by price gouging life-saving medicine.
Correction: This story initially misidentified the use of the drug that received the price hike.